This inventor holds 1 USPTO granted patent and 11 published patent applications. Top assignee: Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment by Zhipeng Cheng
Introduction
Zhipeng Cheng is an innovative inventor based in Guangdong, China. He has made significant contributions to the field of biomedical technology, particularly in the development of drugs aimed at treating brain tumors. His work focuses on enhancing the body's immunological functions to combat this serious health issue.
Latest Patents
Zhipeng Cheng holds a patent for a drug designed for preventing and/or treating brain tumors. The patent details a drug that comprises various components aimed at regulating immunological functions and inflammation-related factors. This drug has shown significant preventive and therapeutic effects on brain tumors by breaking through the blood-brain barrier, fully activating immunocompetence, and inhibiting tumor growth. This innovative approach aims to extend the lifespan of patients suffering from brain tumors.
Career Highlights
Cheng is currently associated with Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd., where he continues to work on groundbreaking research and development in the biomedical field. His dedication to improving cancer treatment options has positioned him as a notable figure in the industry.
Collaborations
Some of his coworkers include Li Qin and Xiaoping Chen, who contribute to the collaborative efforts in advancing biomedical technologies.
Conclusion
Zhipeng Cheng's innovative work in developing a drug for brain tumor treatment exemplifies the potential of biomedical research to improve patient outcomes. His contributions are paving the way for future advancements in cancer therapies.